Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of OQLQ Scores with Treatment Acceptance in Orthognathic Surgery: A Cross-Sectional Study.

Journal of clinical medicine·2026
Same author

Counterfactual Harm: A Counter-argument.

American journal of epidemiology·2026
Same author

Causal Inference in Studies with Functional Unmasking: Psychedelics and Beyond.

medRxiv : the preprint server for health sciences·2025
Same author

Choosing a sensible contrast makes "prevalence bias" irrelevant in screening colonoscopy trials.

European journal of epidemiology·2025
Same author

A positivity robust strategy to study effects of switching treatment.

Biometrics·2025
Same author

How hazard ratios can mislead and why it matters in practice.

European journal of epidemiology·2025
Same journal

Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

American journal of epidemiology·2026
Same journal

Correction to: Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims-the ARIC Study.

American journal of epidemiology·2026
Same journal

RE: advancing observational research on arts and health: theory-informed approaches using the RADIANCE framework.

American journal of epidemiology·2026
Same journal

Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

American journal of epidemiology·2026
Same journal

Immigration and epigenetic age acceleration in the health and retirement study: differences Between Hispanics and Non-Hispanics.

American journal of epidemiology·2026
Same journal

Age-period-cohort analysis of low birth weight, early term delivery, induction and csection, US births 1990-2019.

American journal of epidemiology·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

Gellért Perényi1, Matias Janvin2,3, Mats J Stensrud1

  • 1Institute of Mathematics, École Polytechnique Fédérale de Lausanne (EPFL), Switzerland.

American Journal of Epidemiology
|July 1, 2026
PubMed
Summary
This summary is machine-generated.

Quantifying vaccine efficacy waning is crucial. A new statistical test provides a powerful method to detect waning vaccine effects over time, even with existing clinical trial data.

Keywords:
causal inferencechallenge trialhypothesis testvaccine waning

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Area of Science:

  • Epidemiology
  • Biostatistics
  • Vaccinology

Background:

  • Assessing vaccine efficacy waning is vital for public health decisions.
  • Traditional methods for quantifying waning efficacy rely on strong assumptions.
  • Existing causal estimands for waning have limitations in practical application.

Purpose of the Study:

  • To develop a formal statistical test for assessing constant vaccine treatment effect over time at the individual level.
  • To provide a powerful and valid method for detecting vaccine efficacy waning under interpretable assumptions.
  • To offer new bounds for the waning effect and reanalyze existing vaccine trial data.

Main Methods:

  • Proposed a novel formal test for time-constant treatment effects at the individual level.
  • Developed methods to bound the waning effect.
  • Utilized three approaches for computing test statistics, including two based on summary data.
  • Reanalyzed data from a randomized controlled trial of the BNT162b2 COVID-19 vaccine.

Main Results:

  • The proposed test demonstrates considerable power gain over existing approaches.
  • The test is valid under interpretable assumptions suitable for vaccine trials.
  • Reanalysis of the BNT162b2 vaccine trial data rejected the null hypothesis of no waning.
  • New results provide bounds for the waning effect.

Conclusions:

  • The new statistical test offers a powerful tool for detecting vaccine efficacy waning.
  • This method is applicable to existing clinical trial data, including summary statistics.
  • The findings suggest that waning of BNT162b2 vaccine efficacy can be detected with the proposed method.